Skip to main content

Table 1 Anti-microbial drug susceptibility test results for Mycobacterium abscessus subsp. bolletii isolate

From: Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report

Anti-microbial agent

Minimum inhibitory concentration (MIC) (μg/mL)

Interpretive criteria [[7]]

Amikacina

32

Intermediate

Amoxicillin clavulanateb

>256

Resistant

Cefotaximec (disk, 30μg)

>64

Resistant

Cefoxitinb

<8

Susceptible

Ciprofloxacina

>16

Resistant

Clarithromycina

16

Resistant

Cotrimoxazolec (disk, 1.25/23.75μg)

>8

Resistant

Erythromycinc (disk, 15μg)

>8

Resistant

Imipenemb

0.75

Susceptible

Levofloxacinc (disk, 5μg)

>4

Resistant

Linezolidc (disk, 30μg)

>8

Intermediate/Resistant

Minocyclinec (disk, 30μg)

<4

Susceptible

Ofloxacinc (disk, 5μg)

>8

Resistant

Teicoplaninb

>256

Resistant

Tobramycinc (disk, 10μg)

>8

Resistant

Tigecyclineb

>256

Resistant

Vancomycinb

>256

Resistant

  1. aBroth microdilution; bEtest® (AB Biodisk) at 30°C for 72 hours incubation; cdisk diffusion.